Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
77.8M
-
Shares change
-
-6.38M
-
Total reported value, excl. options
-
$979M
-
Value change
-
-$115M
-
Put/Call ratio
-
0.63
-
Number of buys
-
96
-
Number of sells
-
-78
-
Price
-
$12.58
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q1 2019
219 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q1 2019.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77.8M shares
of 117M outstanding shares and own 66.66% of the company stock.
Largest 10 shareholders include JPMORGAN CHASE & CO (7.48M shares), VANGUARD GROUP INC (6.02M shares), Capital Research Global Investors (4.96M shares), BlackRock Inc. (4.79M shares), RIVERBRIDGE PARTNERS LLC (3.58M shares), DIMENSIONAL FUND ADVISORS LP (3.53M shares), Bank of New York Mellon Corp (3.52M shares), EAGLE ASSET MANAGEMENT INC (2.24M shares), Standard Life Aberdeen plc (2.18M shares), and WADDELL & REED FINANCIAL INC (1.9M shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.